The Cache County Study on Memory in Aging: Factors affecting risk of Alzheimer's disease and its progression after onset

References

• Aalten, P., de Vugt, M.E., Lousberg, R., Korten, E., Jaspers, N., Senden, B., … Verhey, F.R. (2003). Behavioral problems in dementia: A factor analysis of the neuropsychiatric inventory. Dementia and Geriatric Cognitive Disorders, 15, 99–105.
   PubMed Web of Science ®Google Scholar
• Adak, S., Illouz, K., Gorman, W., Tandon, R., Zimmerman, E. A., Guariglia, R., … Kaye, J.A. (2004). Predicting the rate of cognitive decline in aging and early Alzheimer disease. Neurology, 63, 108–114.
   PubMed Web of Science ®Google Scholar
• ADAPT Research Group. (2006). Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's disease anti-inflammatory prevention trial (ADAPT). PLoS Clinical Trials, 1, e33.
   PubMedGoogle Scholar
• ADAPT Research Group, Lyketsos, C.G., Breitner, J.C., Green, R.C., Martin, B.K., Meinert, C., … Sabbagh, M. (2007). Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology, 68, 1800–1808.
   PubMed Web of Science ®Google Scholar
• Aguero-Torres, H., Fratiglioni, L., Guo, Z., Viitanen, M. & Winblad, B. (1998a). Prognostic factors in very old demented adults: A seven-year follow-up from a population-based survey in Stockholm. Journal of the American Geriatrics Society46, 444–452.
   PubMed Web of Science ®Google Scholar
• Aguero-Torres, H., Fratiglioni, L. & Winblad, B. (1998b). Natural history of Alzheimer's disease and other dementias: Review of the literature in the light of the findings from the Kungsholmen Project. International Journal of Geriatric Psychiatry, 13, 755–766.
   PubMed Web of Science ®Google Scholar
• Aisen, P.S., Schmeidler, J. & Pasinetti, G.M. (2002). Randomized pilot study of nimesulide treatment in Alzheimer's disease. Neurology, 58, 1050–1054.
   PubMed Web of Science ®Google Scholar
• Aisen, P.S., Schafer, K.A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K.L., … Thal, L.J. (2003). Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: A randomized controlled trial. Journal of the American Medical Association, 289, 2819–2826.
   PubMed Web of Science ®Google Scholar
• Andersen-Ranberg, K., Vasegaard, L. & Jeune, B. (2001). Dementia is not inevitable: A population-based study of Danish centenarians. Journal of Gerontology B Psychological Science, 56, P152–159.
   PubMed Web of Science ®Google Scholar
• Anthony, J.C., Breitner, J.C., Zandi, P.P., Meyer, M.R., Jurasova, I., Norton, M.C. & Stone, S.V. (2000). Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: The Cache County Study. Neurology, 54, 2066–2071.
   PubMed Web of Science ®Google Scholar
• Asthana, S., Baker, L.D., Craft, S., Stanczyk, F.Z., Veith, R.C., Raskind, M.A. & Plymate, S.R. (2001). High-dose estradiol improves cognition for women with AD: Results of a randomized study. Neurology, 57, 605–612.
   PubMed Web of Science ®Google Scholar
• Barnhart, R.L., van Belle, G., Edland, S.D. & Larson, E. (1997). Referral bias in Alzheimer's disease. Journal of Clinical Epidemiology, 50, 365–366.
   PubMed Web of Science ®Google Scholar
• Behl, P., Stefurak, T.L. & Black, S.E. (2005). Progress in clinical neurosciences: Cognitive markers of progression in Alzheimer's disease. Canadian Journal of Neurological Sciences, 32, 140–151.
   PubMed Web of Science ®Google Scholar
• Borenstein, A.R., Wu, Y., Mortimer, J.A., Schellenberg, G.D., McCormick, W.C., Bowen, J.D., … Larson, E.B. (2005). Developmental and vascular risk factors for Alzheimer's disease. Neurobiolology of Aging, 26, 325–334.
   PubMed Web of Science ®Google Scholar
• Bosch, J., Yusuf, S., Pogue, J., Sleight, P., Lonn, E., Rangoonwala, B., … Probstfield, J. (2002). Use of ramipril in preventing stroke: Double blind randomised trial. British Medical Journal, 324, 699–702.
   PubMed Web of Science ®Google Scholar
• Bowler, J.V., Munoz, D.G., Merskey, H., & Hachinski, V. (1998). Factors affecting the age of onset and rate of progression of Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry, 65, 184–190.
   PubMed Web of Science ®Google Scholar
• Breitner, J.C. & Zandi, P.P. (2003). Effects of estrogen plus progestin on risk of dementia. Journal of the American Medical Association, 290, 1706–1707.
   PubMedGoogle Scholar
• Breitner, J.C., Haneuse, S.J., Walker, R., Dublin, S., Crane, P.K., Gray, S. L., Larson, E.B. (2009). Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort. Neurology, 72, 1899–1905.
   PubMed Web of Science ®Google Scholar
• Breitner, J.C.S. & Miech, R.A. (2000). ApoE-E4 count predicts age when prevalence of AD increases, then declines – Correction. Neurology, 55, 161–162.
   Web of Science ®Google Scholar
• Breitner, J.C., Welsh, K.A., Gau, B.A., McDonald, W.M., Steffens, D.C., Saunders, A.M., … Folstein, M.F. (1995). Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. Archives of Neurology, 52, 763–771.
   PubMedGoogle Scholar
• Brenner, D.E., Kukull, W.A., Stergachis, A., van Belle, G., Bowen, J.D., McCormick, W.C., … Larson, E.B. (1994). Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: A population-based case-control study. American Journal of Epidemiology, 140, 262–267.
   PubMed Web of Science ®Google Scholar
• Brinton, R.D. & Nilsen, J. (2003). Effects of estrogen plus progestin on risk of dementia. Journal of the American Medical Association, 290, 1706.
   PubMed Web of Science ®Google Scholar
• Carlson, M.C., Zandi, P.P., Plassman, B.L., Tschanz, J.T., Welsh-Bohmer, K.A., Steffens, D.C., … Breitner, J.C. (2001). Hormone replacement therapy and reduced cognitive decline in older women: The Cache County Study. Neurology, 57, 2210–2216.
   PubMed Web of Science ®Google Scholar
• Corrada, M.M., Brookmeyer, R., Paganini-Hill, A., Berlau, D. & Kawas, C.H. (2010). Dementia incidence continues to increase with age in the oldest old: The 90 + study. Annals of Neurolology, 67, 114–121.
   PubMed Web of Science ®Google Scholar
• Farrer, L.A., Cupples, L.A., Haines, J.L., Hyman, B., Kukull, W.A., Mayeux, R., … Van Duijn, C.M. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein e genotype and alzheimer disease. A meta-analysis. ApoE and Alzheimer disease meta analysis consortium. Journal of the American Medical Association, 278, 1349–1356.
   PubMed Web of Science ®Google Scholar
• Fauth, E., Hess, K., Piercy, K., Norton, M., Corcoran, C., Rabins, P., … Tschanz, J. (2012). Caregivers’ relationship closeness with the person with dementia predicts both positive and negative outcomes for caregivers’ physical health and psychological well-being. Aging and Mental Health, 16, 699–711.
   PubMed Web of Science ®Google Scholar
• Fauth, E.B., Schwartz, S., Tschanz, J.T., Ostbye, T., Corcoran, C. & Norton, M.C. (2013). Baseline disability in activities of daily living predicts dementia risk even after controlling for baseline global cognitive ability and depressive symptoms. International Journal of Geriatric Psychiatry, 28, 597–606.
   PubMed Web of Science ®Google Scholar
• Forette, F., Seux, M.L., Staessen, J.A., Thijs, L., Babarskiene, M.R., Babeanu, S., … Birkenhager, W.H. (2002). The prevention of dementia with antihypertensive treatment: New evidence from the systolic hypertension in Europe (Syst-Eur) study. Archives of Internal Medicine, 162, 2046–2052.
   PubMed Web of Science ®Google Scholar
• Forette, F., Seux, M.L., Staessen, J.A., Thijs, L., Birkenhager, W.H., Babarskiene, M.R., … Fagard, R. (1998). Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet, 352, 1347–1351.
   PubMed Web of Science ®Google Scholar
• Frisoni, G.B., Rozzini, L., Gozzetti, A., Binetti, G., Zanetti, O., Bianchetti, A., … Cummings, J.L. (1999). Behavioral syndromes in alzheimer's disease: Description and correlates. Dementia and Geriatric Cognitive Disorders, 10, 130–138.
   PubMed Web of Science ®Google Scholar
• Ganguli, M., Snitz, B.E., Saxton, J.A., Chang, C.C., Lee, C.W., Vander Bilt, J., … Petersen, R.C. (2011). Outcomes of mild cognitive impairment by definition: A population study. Archives of Neurology, 68, 761–767.
   PubMedGoogle Scholar
• Gao, S., Hendrie, H.C., Hall, K.S. & Hui, S. (1998). The relationships between age, sex, and the incidence of dementia and alzheimer disease: A meta-analysis. Archives of General Psychiatry, 55, 809–815.
   PubMed Web of Science ®Google Scholar
• Garre-Olmo, J., Lopez-Pousa, S., Vilalta-Franch, J., De Gracia Blanco, M. & Vilarrasa, A.B. (2010). Grouping and trajectories of the neuropsychiatric symptoms in patients with Alzheimer's disease, part I: Symptom clusters. Journal of Alzheimer's Disease, 22, 1157–1167.
   PubMed Web of Science ®Google Scholar
• Graham, J.E., Rockwood, K., Beattie, B.L., Eastwood, R., Gauthier, S., Tuokko, H. & Mcdowell, I. (1997). Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet, 349, 1793–1796.
   PubMed Web of Science ®Google Scholar
• Greene, D., Tschanz, J.T., Smith, K.R., Ostbye, T., Corcoran, C., Welsh-Bohmer, K.A. & Norton, M.C. (2013). Impact of offspring death on cognitive health in late life. The Cache County Study. American Journal of Geriatric Psychiatry, doi: 10.1016/j.jagp.2013.05.002.
   PubMed Web of Science ®Google Scholar
• Gustafson, D. (2008). A life course of adiposity and dementia. European Journal of Pharmacology, 585, 163–175.
   PubMed Web of Science ®Google Scholar
• Hajjar, I., Schumpert, J., Hirth, V., Wieland, D. & Eleazer, G.P. (2002). The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment. Journals of Gerontology A Biological & Medical Science, 57, M414–418.
   PubMed Web of Science ®Google Scholar
• Hall, C.B., Verghese, J., Sliwinski, M., Chen, Z., Katz, M., Derby, C. & Lipton, R.B. (2005). Dementia incidence may increase more slowly after age 90: Results from the Bronx Aging Study. Neurology, 65, 882–886.
   PubMed Web of Science ®Google Scholar
• Hayden, K.M. & Welsh-Bohmer, K.A. (2012). Epidemiology of cognitive aging and Alzheimer's disease: Contributions of the Cache County Utah Study of Memory, Health and Aging. Current Topics in Behavioral Neuroscience. Berlin: Springer.
   Google Scholar
• Hayden, K.M., Zandi, P.P., Khachaturian, A.S., Szekely, C.A., Fotuhi, M., Norton, M.C., … Welsh-Bohmer, K.A. (2007). Does NSAID use modify cognitive trajectories in the elderly? The Cache County Study. Neurology, 69, 275–282.
   PubMed Web of Science ®Google Scholar
• Hayden, K.M., Zandi, P.P., Lyketsos, C.G., Khachaturian, A.S., Bastian, L.A., Charoonruk, G., … Welsh-Bohmer, K.A. (2006). Vascular risk factors for incident Alzheimer disease and vascular dementia: The Cache County Study. Alzheimer Disease and Associated Disorders, 20, 93–100.
   PubMed Web of Science ®Google Scholar
• Henderson, V.W., Paganini-Hill, A., Miller, B.L., Elble, R.J., Reyes, P.F., Shoupe, D., … Farlow, M.R. (2000). Estrogen for Alzheimer's disease in women: Randomized, double-blind, placebo-controlled trial. Neurology, 54, 295–301.
   PubMed Web of Science ®Google Scholar
• Hofman, A., Ott, A., Breteler, M.M., Bots, M.L., Slooter, A.J., Van Harskamp, … Grobbee, D.E. (1997). Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet, 349, 151–154.
   PubMed Web of Science ®Google Scholar
• Jellinger, K.A. (2006). Clinicopathological analysis of dementia disorders in the elderly – An update. Journal of Alzheimer's Disease, 9(Suppl.3), 61–70.
   PubMed Web of Science ®Google Scholar
• Jick, H., Zornberg, G.L., Jick, S.S., Seshadri, S. & Drachman, D.A. (2000). Statins and the risk of dementia. Lancet, 356, 1627–1631.
   PubMed Web of Science ®Google Scholar
• Kawas, C., Resnick, S., Morrison, A., Brookmeyer, R., Corrada, M., Zonderman, A., … Metter, E. (1997). A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology, 48, 1517–1521.
   PubMed Web of Science ®Google Scholar
• Kawas, C.H. & Corrada, M.M. (2006). Alzheimer's and dementia in the oldest-old: A century of challenges. Current Alzheimer Research, 3, 411–419.
   PubMedGoogle Scholar
• Khachaturian, A.S., Corcoran, C.D., Mayer, L.S., Zandi, P.P. & Breitner, J.C. (2004). Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study. Archives of General Psychiatry, 61, 518–524.
   PubMed Web of Science ®Google Scholar
• Khachaturian, A.S., Zandi, P.P., Lyketsos, C.G., Hayden, K.M., Skoog, I., Norton, M.C. … Breitner, J.C. (2006). Antihypertensive medication use and incident Alzheimer disease: The Cache County Study. Archives of Neurology, 63, 686–692.
   PubMed Web of Science ®Google Scholar
• Kivipelto, M., Helkala, E.L., Laakso, M.P., Hanninen, T., Hallikainen, M., Alhainen, K., … Nissinen, A. (2001). Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population based study. British Medical Journal, 322, 1447–1451.
   PubMed Web of Science ®Google Scholar
• Larrieu, S., Letenneur, L., Orgogozo, J.M., Fabrigoule, C., Amieva, H., Le Carret, N., … Dartigues, J.F. (2002). Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology, 59, 1594–1599.
   PubMed Web of Science ®Google Scholar
• Launer, L.J., Ross, G.W., Petrovitch, H., Masaki, K., Foley, D., White, L.R. & Havlik, R.J. (2000). Midlife blood pressure and dementia: The Honolulu-Asia Aging Study. Neurobiology of Aging, 21, 49–55.
   PubMed Web of Science ®Google Scholar
• Leoutsakos, J.M., Han, D., Mielke, M.M., Forrester, S.N., Tschanz, J.T., Corcoran, C.D., … Lyketsos, C.G. (2012). Effects of general medical health on Alzheimer's progression: The Cache County Dementia Progression Study. International Psychogeriatrics, 24, 1561–1570.
   PubMed Web of Science ®Google Scholar
• Li, G., Higdon, R., Kukull, W.A., Peskind, E., Van Valen Moore, K., Tsuang, D., … Larson, E.B. (2004). Statin therapy and risk of dementia in the elderly: A community-based prospective cohort study. Neurology, 63, 1624–1628.
   PubMed Web of Science ®Google Scholar
• Lopez, O.L., Kuller, L.H., Becker, J.T., Dulberg, C., Sweet, R.A., Gach, H.M. & Dekosky, S.T. (2007). Incidence of dementia in mild cognitive impairment in the Cardiovascular Health Study Cognition Study. Archives of Neurology, 64, 416–420.
   PubMedGoogle Scholar
• Luchsinger, J.A., Reitz, C., Honig, L.S., Tang, M.X., Shea, S. & Mayeux, R. (2005). Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology, 65, 545–551.
   PubMed Web of Science ®Google Scholar
• Luchsinger, J.A., Tang, M.X., Shea, S. & Mayeux, R. (2003). Antioxidant vitamin intake and risk of Alzheimer disease. Archives of Neurology, 60, 203–208.
   PubMed Web of Science ®Google Scholar
• Lyketsos, C.G., Carrillo, M.C., Ryan, J.M., Khachaturian, A.S., Trzepacz, P., Amatniek, J., … Miller, D.S. (2011). Neuropsychiatric symptoms in Alzheimer's Disease. Alzheimers & Dementia, 7, 532–9.
   PubMedGoogle Scholar
• Lyketsos, C.G., Sheppard, J.M., Steinberg, M., Tschanz, J.A., Norton, M.C., Steffens, D.C. & Breitner, J.C. (2001). Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: The Cache County Study. International Journal of Geriatrric Psychiatry, 16, 1043–1053.
   PubMed Web of Science ®Google Scholar
• Lyketsos, C.G., Toone, L., Tschanz, J., Rabins, P.V., Steinberg, M., Onyike, C.U., … Williams, M. (2005). Population-based study of medical comorbidity in early dementia and ‘cognitive impairment, no dementia (CIND)’: Association with functional and cognitive impairment: The Cache County Study. American Journal of Geriatric Psychiatry, 13, 656–664.
   PubMed Web of Science ®Google Scholar
• Martin, B.K., Szekely, C., Brandt, J., Piantadosi, S., Breitner, J.C., Craft, S., … Mullan, M. (2008). Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): Results of a randomized, controlled trial of naproxen and celecoxib. Archives of Neurology, 65, 896–905.
   PubMed Web of Science ®Google Scholar
• Miech, R.A., Breitner, J.C., Zandi, P.P., Khachaturian, A.S., Anthony, J.C. & Mayer, L. (2002). Incidence of AD may decline in the early 90s for men, later for women: The Cache County Study. Neurology, 58, 209–218.
   PubMed Web of Science ®Google Scholar
• Mielke, M.M., Leoutsakos, J.M., Corcoran, C.D., Green, R.C., Norton, M.C., Welsh-Bohmer, K.A., … Lyketsos, C.G. (2012a). Effects of food and drug administration-approved medications for Alzheimer's Disease on clinical progression. Alzheimer's and Dementia, 8, 180–187.
   PubMed Web of Science ®Google Scholar
• Mielke, M.M., Leoutsakos, J.M., Tschanz, J.T., Green, R.C., Tripodis, Y., Corcoran, C.D., … Lyketsos, C.G., 2012b. Interaction between vascular factors and the ApoE epsilon4 allele in predicting rate of progression in Alzheimer's Disease. Journal of Alzheimer's Disease, 26, 127–134.
   Web of Science ®Google Scholar
• Mielke, M.M., Rosenberg, P.B., Tschanz, J., Cook, L., Corcoran, C., Hayden, K.M., … Lyketsos, C.G. (2007). Vascular factors predict rate of progression in Alzheimer Disease. Neurology, 69, 1850–1858.
   PubMed Web of Science ®Google Scholar
• Mitchell, A.J. & Shiri-Feshki, M. (2009). Rate of progression of mild cognitive impairment to dementia – Meta-analysis of 41 robust inception cohort studies. Acta Psychiatrica Scandinavica, 119, 252–265.
   PubMed Web of Science ®Google Scholar
• Moceri, V.M., Kukull, W.A., Emanual, I., Van Belle, G., Starr, J.R., Schellenberg, G.D., … Larson, E.B. (2001). Using census data and birth certificates to reconstruct the early-life socioeconomic environment and the relation to the development of Alzheimer's Disease. Epidemiology, 12, 383–389.
   PubMed Web of Science ®Google Scholar
• Moceri, V.M., Kukull, W.A., Emanuel, I., Van Belle, G. & Larson, E.B. (2000). Early-life risk factors and the development of Alzheimer's disease. Neurology, 54, 415–420.
   PubMed Web of Science ®Google Scholar
• Morris, M.C., Beckett, L.A., Scherr, P.A., Hebert, L.E., Bennett, D.A., Field, T.S. & Evans, D.A. (1998). Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Disease and Associated Disorders, 12, 121–126.
   PubMed Web of Science ®Google Scholar
• Morris, M.C., Evans, D.A., Bienias, J.L., Tangney, C.C., Bennett, D.A., Wilson, R.S., … Schneider, J. (2003). Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Archives of Neurology, 60, 940–946.
   PubMed Web of Science ®Google Scholar
• Morris, M.C., Evans, D.A., Tangney, C.C., Bienias, J.L. & Wilson, R.S. (2005). Fish consumption and cognitive decline with age in a large community study. Archives of Neurology, 62, 1849–1853.
   PubMedGoogle Scholar
• Mortimer, J.A., Ebbitt, B., Jun, S.P. & Finch, M.D. (1992). Predictors of cognitive and functional progression in patients with probable Alzheimer's disease. Neurology, 42, 1689–1696.
   PubMed Web of Science ®Google Scholar
• MRC CFAS (Medical Research Council Cognitive Function and Aging Group). (2001). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet, 357, 169–175.
   PubMed Web of Science ®Google Scholar
• Mulnard, R.A., Cotman, C.W., Kawas, C., Van Dyck, C.H., Sano, M., Doody, R., … Thal, L.J. (2000). Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: A randomized controlled trial. Alzheimer's Disease Cooperative Study. Journal of the American Medical Association, 283, 1007–1015.
   PubMed Web of Science ®Google Scholar
• Murray, C., Michaud, C., Mckenna, M. & Marks, J. (1998). U.S. Patterns of mortality by county and race: 1965–1994. Cambridge, MA: Harvard School of Public Health.
   Google Scholar
• Nelson, C., Wengreen, H.J., Munger, R.G. & Corcoran, C.D. (2009). Dietary folate, vitamin B12, vitamin B6 and incident Alzheimer's disease: The Cache County Memory, Health and Aging Study. Journal of Nutrition, Health and Aging, 13, 899–905.
   PubMed Web of Science ®Google Scholar
• Norton, M.C., Clark, C., Fauth, E.B., Piercy, K.W., Pfister, R., Green, R.C., … Tschanz, J.T. (2013a). Caregiver personality predicts rate of cognitive decline in a community sample of persons with Alzheimer's disease. The Cache County Dementia Progression Study. International Psychogeriatrics 25, 1629–1637.
   PubMed Web of Science ®Google Scholar
• Norton, M.C., Dew, J., Smith, H., Fauth, E., Piercy, K.W., Breitner, J.C., … Welsh-Bohmer, K. (2012). Lifestyle behavior pattern is associated with different levels of risk for incident dementia and Alzheimer's disease: The Cache County Study. Journal of the American Geriatrics Society, 60, 405–412.
   PubMed Web of Science ®Google Scholar
• Norton, M.C., Ostbye, T., Smith, K.R., Munger, R.G. & Tschanz, J.T. (2009a). Early parental death and late-life dementia risk: Findings from the Cache County Study. Age and Ageing, 38, 340–343.
   PubMed Web of Science ®Google Scholar
• Norton, M.C., Piercy, K.W., Rabins, P.V., Green, R.C., Breitner, J.C., Ostbye, T., … Tschanz, J.T. (2009b). Caregiver-recipient closeness and symptom progression in Alzheimer disease. The Cache County Dementia Progression Study. Journals of Gerontology B Psychological Sciences, 64, 560–568.
   Google Scholar
• Norton, M.C., Smith, K.R., Ostbye, T., Tschanz, J.T., Corcoran, C., Schwartz, S., … Welsh-Bohmer, K.A. (2010). Greater risk of dementia when spouse has dementia? The Cache County Study. Journal of the American Geriatrics Society, 58, 895–900.
   PubMed Web of Science ®Google Scholar
• Norton, M.C., Smith, K.R., Ostbye, T., Tschanz, J.T., Corcoran, C., Schwartz, S., … Welsh-Bohmer, K.A. (2013b). Correction: Greater risk of dementia when spouse has dementia? The Cache County Study. Journal of the American Geriatric Society, 61, 1642.
   Web of Science ®Google Scholar
• Norton, M.C., Smith, K.R., Ostbye, T., Tschanz, J.T., Corcoran, C., Schwartz, S., … Breitner, J.C.S. (2011). Early parental death and remarriage of widowed parents as risk factors for Alzheimer's disease. American Journal of Geriatric Psychiatry, 19, 814–824.
   PubMed Web of Science ®Google Scholar
• Notkola, I.L., Sulkava, R., Pekkanen, J., Erkinjuntti, T., Ehnholm, C., Kivinen, P., … Nissinen, A. (1998). Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology, 17, 14–20.
   PubMed Web of Science ®Google Scholar
• Ott, A., Stolk, R.P., Van Harskamp, F., Pols, H.A., Hofman, A. & Breteler, M.M. (1999). Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology, 53, 1937–1942.
   PubMed Web of Science ®Google Scholar
• Peltz, C.B., Corrada, M.M., Berlau, D.J. & Kawas, C.H. (2011). Incidence of dementia in oldest-old with amnestic MCI and other cognitive impairments. Neurology, 77, 1906–1912.
   PubMed Web of Science ®Google Scholar
• Persson, G. & Skoog, I. (1996). A prospective population study of psychosocial risk factors for late onset dementia. International Journal of Geriatric Psychiatry, 11, 15–22.
   Web of Science ®Google Scholar
• Peters, M.E., Rosenberg, P.B., Steinberg, M., Norton, M.C., Welsh-Bohmer, K.A., Hayden, K.M., … Lyketsos, C.G. (2013). Neuropsychiatric symptoms as risk factors for progression from cind to dementia: The Cache County Study. American Journal of Geriatric Psychiatry, 21, 1116–1124.
   PubMed Web of Science ®Google Scholar
• Peters, M.E., Rosenberg, P.B., Steinberg, M., Tschanz, J.T., Norton, M.C., Welsh-Bohmer, K.A., … Lyketsos, C.G. (2012). Prevalence of neuropsychiatric symptoms in CIND and its subtypes: The Cache County Study. American Journal of Geriatric Psychiatry, 20, 416–424.
   PubMed Web of Science ®Google Scholar
• Peters, R., Beckett, N., Forette, F., Tuomilehto, J., Clarke, R., Ritchie, C., … Bulpitt, C. (2008). Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial Cognitive Function Assessment (HYVET-cog): A double-blind, placebo controlled trial. Lancet Neurology, 7, 683–689.
   PubMed Web of Science ®Google Scholar
• Petersen, R.C., Thomas, R.G., Grundman, M., Bennett, D., Doody, R., Ferris, S., … Thal, L.J. (2005). Vitamin E and donepezil for the treatment of mild cognitive impairment. New England Journal of Medicine, 352, 2379–2388.
   PubMed Web of Science ®Google Scholar
• Piercy, K.W., Fauth, E.B., Norton, M.C., Pfister, R., Corcoran, C.D., Rabins, P.V., … Tschanz, J.T. (2013). Predictors of dementia caregiver depressive symptoms in a population: The Cache County Dementia Progression Study. Journals of Gerontology B Psychological Sciences Social Sciences,68, 921–926.
   PubMed Web of Science ®Google Scholar
• Plassman, B.L., Langa, K.M., Fisher, G.G., Heeringa, S.G., Weir, D.R., Ofstedal, M.B., … Wallace, R.B. (2007). Prevalence of dementia in the United States: The Aging, Demographics, and Memory Study. Neuroepidemiology, 29, 125–132.
   PubMed Web of Science ®Google Scholar
• Quinn, J.F., Raman, R., Thomas, R.G., Yurko-Mauro, K., Nelson, E.B., Van Dyck, C., … Aisen, P.S. (2010). Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial. Journal of the American Medical Association, 304, 1903–1911.
   PubMed Web of Science ®Google Scholar
• Rabins, P.V., Schwartz, S., Black, B.S., Corcoran, C., Fauth, E., Mielke, M., … Tschanz, J. (2013). Predictors of progression to severe Alzheimer's disease in an incidence sample. Alzheimer's and Dementia, 9, 204–207.
   PubMed Web of Science ®Google Scholar
• Rapp, S.R., Espeland, M.A., Shumaker, S.A., Henderson, V.W., Brunner, R.L., Manson, J.E., … Bowen, D. (2003). Effect of estrogen plus progestin on global cognitive function in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial. Journal of the American Medical Association, 289, 2663–2672.
   PubMed Web of Science ®Google Scholar
• Rea, T.D., Breitner, J.C., Psaty, B.M., Fitzpatrick, A.L., Lopez, O.L., Newman, A.B., … Kuller, L.H. (2005). Statin use and the risk of incident dementia: The Cardiovascular Health Study. Archives of Neurology, 62, 1047–1051.
   PubMed Web of Science ®Google Scholar
• Reines, S.A., Block, G.A., Morris, J.C., Liu, G., Nessly, M.L., Lines, C.R., … Baranak, C.C. (2004). Rofecoxib: No effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study. Neurology, 62, 66–71.
   PubMed Web of Science ®Google Scholar
• Reitz, C., Den Heijer, T., Van Duijn, C., Hofman, A. & Breteler, M.M. (2007). Relation between smoking and risk of dementia and Alzheimer disease: The Rotterdam Study. Neurology, 69, 998–1005.
   PubMed Web of Science ®Google Scholar
• Resnick, S.M. & Henderson, V.W. (2002). Hormone therapy and risk of Alzheimer disease: A critical time. Journal of the American Medical Association, 288, 2170–2172.
   PubMed Web of Science ®Google Scholar
• Rockwood, K., Kirkland, S., Hogan, D.B., Macknight, C., Merry, H., Verreault, R., … Mcdowell, I. (2002). Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Archives of Neurology, 59, 223–227.
   PubMed Web of Science ®Google Scholar
• Rosenberg, P.B., Mielke, M.M., Han, D., Leoutsakos, J.S., Lyketsos, C.G., Rabins, P.V., … Tschanz, J.T. (2012). The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease. International Journal of Geriatric Psychiatry, 27, 1248–1257.
   PubMed Web of Science ®Google Scholar
• Rosenberg, P.B., Mielke, M.M., Tschanz, J., Cook, L., Corcoran, C., Hayden, K.M., … Lyketsos, C.G. (2008). Effects of cardiovascular medications on rate of functional decline in Alzheimer disease. American Journal of Geriatric Psychiatry, 16, 883–892.
   PubMed Web of Science ®Google Scholar
• Ruitenberg, A., Ott, A., Van Swieten, J.C., Hofman, A. & Breteler, M.M. (2001). Incidence of dementia: Does gender make a difference? Neurobiology of Aging, 22, 575–580.
   PubMed Web of Science ®Google Scholar
• Santanello, N.C., Barber, B.L., Applegate, W.B., Elam, J., Curtis, C., Hunninghake, D.B. & Gordon, D.J. (1997). Effect of pharmacologic lipid lowering on health-related quality of life in older persons: Results from the Cholesterol Reduction in Seniors Program (CRISP) pilot study. Journal of the American Geriatric Society, 45, 8–14.
   PubMed Web of Science ®Google Scholar
• Scarmeas, N., Stern, Y., Tang, M.X., Mayeux, R. & Luchsinger, J.A. (2006). Mediterranean diet and risk for Alzheimer's disease. Annals of Neurology, 59, 912–921.
   PubMed Web of Science ®Google Scholar
• Scharf, S., Mander, A., Ugoni, A., Vajda, F. & Christophidis, N. (1999). A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease. Neurology, 53, 197–201.
   PubMed Web of Science ®Google Scholar
• Schmeidler, J., Mohs, R.C. & Aryan, M. (1998). Relationship of disease severity to decline on specific cognitive and functional measures in Alzheimer disease. Alzheimer Disease and Associated Disorders, 12, 146–151.
   PubMed Web of Science ®Google Scholar
• Seshadri, S., Zornberg, G.L., Derby, L.E., Myers, M.W., Jick, H. & Drachman, D.A. (2001). Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease. Archives of Neurology, 58, 435–440.
   PubMed Web of Science ®Google Scholar
• Shah, K., Qureshi, S.U., Johnson, M., Parikh, N., Schulz, P.E. & Kunik, M.E. (2009). Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review. American Journal of Geriatric Pharmacotherapy, 7, 250–261.
   PubMedGoogle Scholar
• Shao, H., Breitner, J.C., Whitmer, R.A., Wang, J., Hayden, K., Wengreen, H., … Zandi, P.P. (2012). Hormone therapy and Alzheimer disease dementia: New findings from the Cache County Study. Neurology, 79, 1846–1852.
   PubMed Web of Science ®Google Scholar
• Shepherd, J., Blauw, G.J., Murphy, M.B., Bollen, E.L., Buckley, B.M., Cobbe, S.M., … Westendorp, R.G. (2002). Pravastatin in elderly individuals at risk of vascular disease (prosper): A randomised controlled trial. Lancet, 360, 1623–1630.
   PubMed Web of Science ®Google Scholar
• Shumaker, S.A., Legault, C., Kuller, L., Rapp, S.R., Thal, L., Lane, D.S., … Coker, L.H. (2004). Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. Journal of the American Medical Association, 291, 2947–2958.
   PubMed Web of Science ®Google Scholar
• Shumaker, S.A., Legault, C., Rapp, S.R., Thal, L., Wallace, R.B., Ockene, J.K., … Wactawski-Wende, J. (2003). Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial. Journal of the American Medical Association, 289, 2651–2662.
   PubMed Web of Science ®Google Scholar
• Slavin, M.J., Brodaty, H. & Sachdev, P.S. (2013). Challenges of diagnosing dementia in the oldest old population. Journals of Gerontology A Bioliological Sciences Medical Sciences, 68, 1103–1111.
   PubMed Web of Science ®Google Scholar
• Soininen, H., West, C., Robbins, J. & Niculescu, L. (2007). Long-term efficacy and safety of celecoxib in Alzheimer's disease. Dementia, and Geriatric Cognnitive Disorders, 23, 8–21.
   PubMed Web of Science ®Google Scholar
• Steffens, D.C., Norton, M.C., Plassman, B.L., Tschanz, J.T., Wyse, B.W., Welsh-Bohmer, K.A., … Breitner, J.C. (1999). Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women. Journal of the American Geriatrics Society47, 1171–1175.
   PubMed Web of Science ®Google Scholar
• Steinberg, M., Hess, K., Corcoran, C., Mielke, M.M., Norton, M., Breitner, J., … Tschanz, J. (2013). Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: The Cache County Study. International Journal of Geriatric Psychiatry, doi: 10.1002/gps.3980
   PubMed Web of Science ®Google Scholar
• Steinberg, M., Shao, H., Zandi, P., Lyketsos, C.G., Welsh-Bohmer, K.A., Norton, M.C., … Tschanz, J.T. (2008). Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: The Cache County Study. International Journal of Geriatric Psychiatry, 23, 170–177.
   PubMed Web of Science ®Google Scholar
• Steinberg, M., Tschanz, J.T., Corcoran, C., Steffens, D.C., Norton, M.C., Lyketsos, C.G. & Breitner, J.C. (2004). The persistence of neuropsychiatric symptoms in dementia: The Cache County Study. International Journal of Geriatric Psychiatry, 19, 19–26.
   PubMed Web of Science ®Google Scholar
• Stern, Y., Albert, S., Tang, M.X. & Tsai, W.Y. (1999). Rate of memory decline in AD is related to education and occupation: Cognitive reserve? Neurology, 53, 1942–1947.
   PubMed Web of Science ®Google Scholar
• Swanwick, G.R., Coen, R.F., Coakley, D. & Lawlor, B.A. (1998). Assessment of progression and prognosis in ‘possible’ and ‘probable’ Alzheimer's disease. International Journal of Geriatric Psychiatry, 13, 331–335.
   PubMed Web of Science ®Google Scholar
• Tang, M.X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., … Mayeux, R. (1996). Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet, 348, 429–432.
   PubMed Web of Science ®Google Scholar
• Treiber, K.A., Carlson, M.C., Corcoran, C., Norton, M.C., Breitner, J.C., Piercy, K.W., … Tschanz, J.T. (2011). Cognitive stimulation and cognitive and functional decline in Alzheimer's disease: The Cache County Dementia Progression Study. Journals of Gerontology Psychological Sciences Social Sciences, 66, 416–425.
   PubMed Web of Science ®Google Scholar
• Treiber, K.A., Lyketsos, C.G., Corcoran, C., Steinberg, M., Norton, M., Green, R.C., … Tschanz, J.T. (2008). Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: The Cache County Study. International Psychogeriatrics, 20, 538–553.
   PubMed Web of Science ®Google Scholar
• Tschanz, J.T., Corcoran, C., Schwartz, S., Treiber, K., Green, R.C., Norton, M.C., … Lyketsos, C.G. (2011). Progression of cognitive, functional and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: The Cache County Dementia Progression Study. American Journal of Geriatric Psychiatry, 19, 532–542.
   PubMed Web of Science ®Google Scholar
• Tschanz, J.T., Pfister, R., Wanzek, J., Corcoran, C., Smith, K., Tschanz, B.T., … Norton, M.C. (2013a). Stressful life events and cognitive decline in late life: Moderation by education and age. The Cache County Study. International Journal of Geriatric Psychiatry, 28, 821–830.
   PubMed Web of Science ®Google Scholar
• Tschanz, J.T., Piercy, K., Corcoran, C.D., Fauth, E., Norton, M.C., Rabins, P.V., … Lyketsos, C.G. (2013b). Caregiver coping strategies predict cognitive and functional decline in dementia: The Cache County Dementia Progression Study. American Journal of Geriatric Psychiatry, 21, 57–66.
   PubMed Web of Science ®Google Scholar
• Tschanz, J.T., Treiber, K., Norton, M.C., Welsh-Bohmer, K.A., Toone, L., Zandi, P.P., … Breitner, J.C. (2005). A population study of Alzheimer's disease: Findings from the Cache County Study on Memory, Health, and Aging. Care Management Journal, 6, 107–114.
   PubMedGoogle Scholar
• Tschanz, J.T., Welsh-Bohmer, K.A., Lyketsos, C.G., Corcoran, C., Green, R.C., Hayden, K., … Breitner, J.C. (2006). Conversion to dementia from mild cognitive disorder: The Cache County Study. Neurology, 67, 229–234.
   PubMed Web of Science ®Google Scholar
• Tuokko, H., Frerichs, R., Graham, J., Rockwood, K., Kristjansson, B., Fisk, J., … Mcdowell, I. (2003). Five-year follow-up of cognitive impairment with no dementia. Archives of Neurology, 60, 577–582.
   PubMed Web of Science ®Google Scholar
• Tzourio, C., Anderson, C., Chapman, N., Woodward, M., Neal, B., Macmahon, S. & Chalmers, J. (2003). Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Archives of Internal Medicine, 163, 1069–1075.
   PubMed Web of Science ®Google Scholar
• UN (United Nations). (2002). World population ageing: 1950–2050. Retrieved from http://www.un.org/esa/population/publications/worldageing19502050/
   Google Scholar
• US Census. (1990). Retrieved from http://www.census.gov/population/cencoutns/
   Google Scholar
• Wengreen, H.J., Munger, R.G., Corcoran, C.D., Zandi, P., Hayden, K.M., Fotuhi, M., … Welsh-Bohmer, K.A. (2007). Antioxidant intake and cognitive function of elderly men and women: The Cache County Study. Journal of Nutrition, Health and Aging, 11, 230–237.
   PubMed Web of Science ®Google Scholar
• Wengreen, H.J., Neilson, C., Munger, R. & Corcoran, C. (2009). Diet quality is associated with better cognitive test performance among aging men and women. Journal of Nutrition, 139, 1944–1949.
   PubMed Web of Science ®Google Scholar
• Whitmer, R.A., Quesenberry, C.P., Zhou, J. & Yaffe, K. (2011). Timing of hormone therapy and dementia: The critical window theory revisited. Annals of Neurology, 69, 163–169.
   PubMed Web of Science ®Google Scholar
• Whitmer, R.A., Sidney, S., Selby, J., Johnston, S.C. & Yaffe, K. (2005). Midlife cardiovascular risk factors and risk of dementia in late life. Neurology, 64, 277–281.
   PubMed Web of Science ®Google Scholar
• WHO–AD (Alzheimer's Disease) International (2012). Dementia: A Public Health Priority. Geneva: World Health Organization.
   Google Scholar
• Wolozin, B., Kellman, W., Ruosseau, P., Celesia, G.G. & Siegel, G. (2000). Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Archives of Neurology, 57, 1439–1443.
   PubMed Web of Science ®Google Scholar
• Yip, A.G., Green, R.C., Huyck, M., Cupples, L.A. & Farrer, L.A. (2005).Nonsteroidal anti-inflammatory drug use and Alzheimer's disease risk: The MIRAGE Study. British Medical Journal Geriatrics, 5, 2.
   PubMedGoogle Scholar
• Zandi, P.P., Anthony, J.C., Hayden, K.M., Mehta, K., Mayer, L. & Breitner, J.C. (2002a). Reduced incidence of AD with NSAID but not H2 receptor antagonists: The Cache County Study. Neurology, 59, 880–886.
   PubMed Web of Science ®Google Scholar
• Zandi, P.P., Anthony, J.C., Khachaturian, A.S., Stone, S.V., Gustafson, D., Tschanz, J.T., … Breitner, J.C. (2004). Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: The Cache County Study. Archives of Neurology, 61, 82–88.
   PubMed Web of Science ®Google Scholar
• Zandi, P.P., Carlson, M.C., Plassman, B.L., Welsh-Bohmer, K.A., Mayer, L.S., Steffens, D.C. & Breitner, J.C. (2002b). Hormone replacement therapy and incidence of Alzheimer disease in older women: The Cache County Study. Journal of the American Medical Association, 288, 2123–2129.
   PubMed Web of Science ®Google Scholar
• Zandi, P.P., Sparks, D.L., Khachaturian, A.S., Tschanz, J., Norton, M., Steinberg, M., … Breitner, J.C. (2005). Do statins reduce risk of incident dementia and Alzheimer Disease? The Cache County Study. Archives of General Psychiatry, 62, 217–224.
   PubMed Web of Science ®Google Scholar